Panel Discussion: How Best Can We Drive a Patient Centric Approach to Develop Efficacious & Engaging Digital Therapeutics?

Time: 2:05 pm
day: Day Two


• How can we establish digital therapeutics as a meaningful new treatment category for patients?
• How can these new digital therapeutics complement novel treatments being developed specifically for neuropsychiatric diseases?
• What is the best approach to develop these digital therapeutics?
• How can we regulate them? Do you want to combine, pair your drug product with a specific digital therapy?
• How should we program it right and make it user friendly?
• Would a company commission their own digital therapeutic to pair with another companies’ new product?